# Open Label Study of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia

> **NCT03810690** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **ModernaTX, Inc.**

## Conditions studied

- Methylmalonic Acidemia (MMA)
- Metabolism, Inborn Errors

## Interventions

- **BIOLOGICAL:** mRNA-3704

## Key facts

- **NCT ID:** NCT03810690
- **Lead sponsor:** ModernaTX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-05-28
- **Primary completion:** 2020-08-18
- **Final completion:** 2020-08-18
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was terminated before the start of dosing due to a business decision and not due to safety or efficacy reasons.
- **Last updated:** 2020-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03810690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03810690, "Open Label Study of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03810690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*